Despite Strong Income And Revenue Growth LFTD Stock Plunges Following Earnings Release
LFTD Partners Inc. (OTCQB: LIFD) Q2 2022 revenue increased 151% to $16.8 million, up from $6.7 million in Q2 2021.
Q2 2022 Compared to Q2 2021:
Forian Q2 Revenue Grows 44% YoY, Here Are The Details
Forian Inc. (NASDAQ: FORA) released results for the quarter ended June 30, 2022.
Q2 2022 Financial Highlights
Improving Balance Sheet Is Paying Off For Clever Leaves, Q2 Revenue Grows 27% YoY
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) released financial results for the second quarter ended June 30, 2022, revealing revenue increased 27% to $4.7 million compared to $3.7 million in Q2 2021.
Schwazze Q2 Revenue Grows 44% YoY, What About Profit?
Schwazze, (OTCQX: SHWZ) (NEO:SHWZ) released financial results for the second quarter ended June 30, 2022, revealing revenues of $44.3 million, an increase of 44% compared to $30.7 million in Q2 2021.
Cantor Fitzgerald Maintains Overweight on Clever Leaves Holdings, Lowers Price Target to $4.3
Cantor Fitzgerald analyst Pablo Zuanic maintains Clever Leaves Holdings (NASDAQ:CLVR) with a Overweight and lowers the price target from $4.5 to $4.3.
Cantor Fitzgerald Downgrades TerrAscend to Neutral, Lowers Price Target to $2.85
Cantor Fitzgerald analyst Pablo Zuanic downgrades TerrAscend (OTC:TRSSF) from Overweight to Neutral and lowers the price target from $6.45 to $2.85.
New Jersey Adult-Use Sales ‘Got Off To A Great Start’: TerrAscend Second Quarter 2022 Revenue Increases 10% YoY
TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) reported its financial results for the second quarter ending June 30, late Thursday.
Leafly Positioned For Long-Term Growth, Second Quarter Revenue Up 6% Sequentially To $12.1 Million
Recently, Leafly Holdings, Inc. (NASDAQ: LFLY), announced its financial results for its second quarter ended June 30, 2022.
With EFT Defiance Psychedelics Fund Closing, Let’s Take A Look At Market Movement
The fund owning the Defiance Next Gen Altered Experience ETF (NYSEARCA: PSY) and Defiance Next Gen SPAC Derived ETF funds, ETF Series Solutions recently decided to close and liquidate each fund.
Is Cannabis Education A Solution To Prevent Testing Labs From Focusing On THC Potency?
Recently, U.S. industry officials said that "cannabis testing laboratories are partly to blame for the marijuana industry’s focus on delivering high-THC products to consumers."
It could be associated with state regulators' lack of mechanisms to check the accuracy of private laboratory testing results.